Similar articles for PMID: 23073611

Year	Number of Results
1987	1
1991	1
1992	1
1993	1
1994	2
1996	3
1997	3
1998	3
1999	4
2000	8
2001	12
2002	4
2003	8
2004	10
2005	7
2006	7
2007	9
2008	6
2009	6
2010	10
2011	17
2012	13
2013	17
2014	9
2015	12
2016	7
2017	7
2018	17
2019	15
2020	12
2021	12
2022	8
2023	6
2024	0

1

Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.

Kartal Yandım M, Apohan E, Baran Y. Kartal Yandım M, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):13-20. doi: 10.1007/s00280-012-1984-x. Epub 2012 Oct 17. Cancer Chemother Pharmacol. 2013. PMID: 23073611 Review.

2

P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.

Turzanski J, Grundy M, Shang S, Russell N, Pallis M. Turzanski J, et al. Exp Hematol. 2005 Jan;33(1):62-72. doi: 10.1016/j.exphem.2004.10.005. Exp Hematol. 2005. PMID: 15661399 Free article.

3

A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.

Gencer EB, Ural AU, Avcu F, Baran Y. Gencer EB, et al. Ann Hematol. 2011 Nov;90(11):1265-75. doi: 10.1007/s00277-011-1212-5. Epub 2011 Apr 1. Ann Hematol. 2011. PMID: 21455605

4

Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.

Kartal M, Saydam G, Sahin F, Baran Y. Kartal M, et al. Nutr Cancer. 2011;63(4):637-44. doi: 10.1080/01635581.2011.538485. Nutr Cancer. 2011. PMID: 21500096 Free article.

5

Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance.

Ogretmen B, Hannun YA. Ogretmen B, et al. Drug Resist Updat. 2001 Dec;4(6):368-77. doi: 10.1054/drup.2001.0225. Drug Resist Updat. 2001. PMID: 12030784 Review.

6

Sphingolipids and response to chemotherapy.

Dimanche-Boitrel MT, Rebillard A. Dimanche-Boitrel MT, et al. Handb Exp Pharmacol. 2013;(216):73-91. doi: 10.1007/978-3-7091-1511-4_4. Handb Exp Pharmacol. 2013. PMID: 23563652 Review.

7

Ceramide glycosylation potentiates cellular multidrug resistance.

Liu YY, Han TY, Giuliano AE, Cabot MC. Liu YY, et al. FASEB J. 2001 Mar;15(3):719-30. doi: 10.1096/fj.00-0223com. FASEB J. 2001. PMID: 11259390

8

Ceramide synthesis and metabolism as a target for cancer therapy.

Reynolds CP, Maurer BJ, Kolesnick RN. Reynolds CP, et al. Cancer Lett. 2004 Apr 8;206(2):169-80. doi: 10.1016/j.canlet.2003.08.034. Cancer Lett. 2004. PMID: 15013522 Review.

9

The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp function.

Chai L, McLaren RP, Byrne A, Chuang WL, Huang Y, Dufault MR, Pacheco J, Madhiwalla S, Zhang X, Zhang M, Teicher BA, Carter K, Cheng SH, Leonard JP, Xiang Y, Vasconcelles M, Goldberg MA, Copeland DP, Klinger KW, Lillie J, Madden SL, Jiang YA. Chai L, et al. Int J Oncol. 2011 Mar;38(3):701-11. doi: 10.3892/ijo.2010.888. Epub 2010 Dec 24. Int J Oncol. 2011. PMID: 21186402

10

Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.

Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, Iwai K, Tashima M, Uchiyama T, Okazaki T. Itoh M, et al. Clin Cancer Res. 2003 Jan;9(1):415-23. Clin Cancer Res. 2003. PMID: 12538495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

243 results

Results by year